Insider Trading Activity Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) – Chairman Sold 11,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Stanley T Crooke , Chairman of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) reportedly Sold 11,000 shares of the company’s stock at an average price of 55.35 for a total transaction amount of $608,850.00 SEC Form

Insider Trading History For Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

  • On 1/16/2013 Stanley T Crooke, CEO, sold 1,460 with an average share price of $14.00 per share and the total transaction amounting to $20,440.00.View SEC Filing
  • On 5/30/2013 Frederick T Muto, Director, sold 10,000 with an average share price of $21.96 per share and the total transaction amounting to $219,600.00.View SEC Filing
  • On 6/11/2013 Brett P Monia, SVP, sold 9,375 with an average share price of $23.76 per share and the total transaction amounting to $222,750.00.View SEC Filing
  • On 6/20/2013 Joseph H Wender, Director, sold 5,447 with an average share price of $20.93 per share and the total transaction amounting to $114,005.71.View SEC Filing
  • On 6/25/2013 Richard S Geary, SVP, sold 47,049 with an average share price of $26.20 per share and the total transaction amounting to $1,232,683.80.View SEC Filing
  • On 6/26/2013 Stanley T Crooke, CEO, sold 90,000 with an average share price of $26.73 per share and the total transaction amounting to $2,405,700.00.View SEC Filing
  • On 7/1/2013 Stanley T Crooke, CEO, sold 50,683 with an average share price of $27.65 per share and the total transaction amounting to $1,401,384.95.View SEC Filing

    • Analyst Ratings For Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
    These are 2 Sell Ratings, 6 Hold Ratings, 6 Buy Ratings .
    The current consensus rating for Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is Hold (Score: 2.29) with a consensus target price of $44.00 , a potential (26.12% downside)

    Analyst Ratings History For Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

    • On 8/2/2016 Morgan Stanley Initiated Coverage of rating Equal to Equal Weight with a price target of $37.00 to $37.00
    • On 8/2/2016 Barclays PLC Boost Price Target of rating Equal Weight with a price target of $26.00 to $41.00
    • On 9/11/2016 Wells Fargo & Company Reiterated Rating Buy
    • On 11/10/2016 J P Morgan Chase & Co Reiterated Rating Hold with a price target of $35.00
    • On 12/27/2016 Laidlaw Boost Price Target of rating Buy with a price target of $59.00 to $65.00
    • On 1/5/2017 Janney Montgomery Scott Set Price Target of rating Hold with a price target of $44.00
    • On 1/6/2017 Jefferies Group LLC Reiterated Rating Sell with a price target of $17.00

    Recent Trading Activity for Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
    Shares of Ionis Pharmaceuticals, Inc. closed the previous trading session at 59.56 up +3.17 5.62% with 1,742,130 shares trading hands.